{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:57:50Z","timestamp":1787662670371,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["2014.0312"],"award-info":[{"award-number":["2014.0312"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish governmental ALF grants"},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR-BTRU-2015-10032"],"award-info":[{"award-number":["NIHR-BTRU-2015-10032"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinically important MAM blood group antigen is present on haematopoietic cells of all humans except rare MAM-negative individuals. Its molecular basis is unknown. By whole-exome sequencing we identify <jats:italic>EMP3<\/jats:italic>, encoding epithelial membrane protein 3 (EMP3), as a candidate gene, then demonstrate inactivating mutations in ten known MAM-negative individuals. We show that EMP3, a purported tumour suppressor in various solid tumours, is expressed in erythroid cells. Disruption of EMP3 by CRISPR\/Cas9 gene editing in an immortalised human erythroid cell line (BEL-A2) abolishes MAM expression. We find EMP3 to associate with, and stabilise, CD44 in the plasma membrane. Furthermore, cultured erythroid progenitor cells from MAM-negative individuals show markedly increased proliferation and higher reticulocyte yields, suggesting an important regulatory role for EMP3 in erythropoiesis and control of cell production. Our data establish MAM as a new blood group system and demonstrate an interaction of EMP3 with the cell surface signalling molecule CD44.<\/jats:p>","DOI":"10.1038\/s41467-020-17060-4","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T10:02:53Z","timestamp":1594893773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Disruption of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-0997","authenticated-orcid":false,"given":"Nicole","family":"Thornton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-9107","authenticated-orcid":false,"given":"Vanja","family":"Karamatic Crew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Tilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chwen Ling","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7461-0635","authenticated-orcid":false,"given":"Rebecca E.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda K.","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Spring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers","family":"Walser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-4416","authenticated-orcid":false,"given":"Abdul Ghani","family":"Alattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Laundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-2604","authenticated-orcid":false,"given":"Jill R.","family":"Storry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-0046","authenticated-orcid":false,"given":"Mattias","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5536-1207","authenticated-orcid":false,"given":"Lorna","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1798-1189","authenticated-orcid":false,"given":"Richard","family":"Charlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lomas-Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Feick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Seltsam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6238-8405","authenticated-orcid":false,"given":"Beate","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1647-9610","authenticated-orcid":false,"given":"Martin L.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"17060_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ng.2600","volume":"45","author":"JR Storry","year":"2013","unstructured":"Storry, J. R. et al. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat. Genet. 45, 537\u2013541 (2013).","journal-title":"Nat. Genet."},{"key":"17060_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng.1069","volume":"44","author":"V Helias","year":"2012","unstructured":"Helias, V. et al. ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis. Nat. Genet. 44, 170\u2013173 (2012).","journal-title":"Nat. Genet."},{"key":"17060_CR3","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1182\/blood-2004-04-1512","volume":"104","author":"V Karamatic Crew","year":"2004","unstructured":"Karamatic Crew, V. et al. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 104, 2217\u20132223 (2004).","journal-title":"Blood"},{"key":"17060_CR4","first-page":"23S","volume":"33","author":"G Anderson","year":"1993","unstructured":"Anderson, G. et al. An antibody to a high frequency antigen found on red cells, platelets, lymphocytes, and monocytes. Transfusion 33, 23S (1993).","journal-title":"Transfusion"},{"key":"17060_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbamem.2007.10.018","volume":"1778","author":"G Krause","year":"2008","unstructured":"Krause, G. et al. Structure and function of claudins. Biochim. Biophys. Acta 1778, 631\u2013645 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"17060_CR6","doi-asserted-by":"publisher","first-page":"e1327839","DOI":"10.1080\/21688370.2017.1327839","volume":"5","author":"SJ Hagen","year":"2017","unstructured":"Hagen, S. J. Non-canonical functions of claudin proteins: beyond the regulation of cell-cell adhesions. Tissue Barriers 5, e1327839 (2017).","journal-title":"Tissue Barriers"},{"key":"17060_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ajpath.2017.10.021","volume":"188","author":"S Lee","year":"2018","unstructured":"Lee, S. et al. Elevated peripheral myelin protein 22, reduced mitotic potential, and proteasome impairment in dermal fibroblasts from charcot-marie-tooth disease type 1A patients. Am. J. Pathol. 188, 728\u2013738 (2018).","journal-title":"Am. J. Pathol."},{"key":"17060_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14771-5","volume":"7","author":"YC Liao","year":"2017","unstructured":"Liao, Y. C. et al. Clinical and molecular characterization of PMP22 point mutations in Taiwanese patients with inherited neuropathy. Sci. Rep. 7, 15363 (2017).","journal-title":"Sci. Rep."},{"key":"17060_CR9","doi-asserted-by":"publisher","first-page":"e1700220","DOI":"10.1126\/sciadv.1700220","volume":"3","author":"KF Mittendorf","year":"2017","unstructured":"Mittendorf, K. F. et al. Peripheral myelin protein 22 alters membrane architecture. Sci. Adv. 3, e1700220 (2017).","journal-title":"Sci. Adv."},{"key":"17060_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.canlet.2018.05.022","volume":"430","author":"Q Ma","year":"2018","unstructured":"Ma, Q. et al. EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK\/ERK pathway. Cancer Lett. 430, 97\u2013108 (2018).","journal-title":"Cancer Lett."},{"key":"17060_CR11","first-page":"199","volume":"1868","author":"YW Wang","year":"2017","unstructured":"Wang, Y. W., Cheng, H. L., Ding, Y. R., Chou, L. H. & Chow, N. H. EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer. Biochim. Biophys. Acta 1868, 199\u2013211 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"17060_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1365-3148.1997.d01-24.x","volume":"7","author":"AC Petty","year":"1997","unstructured":"Petty, A. C., Green, C. A. & Daniels, G. L. The monoclonal antibody-specific immobilisation of erythrocyte antigens assay (MAIEA) in the investigation of human red-cell antigens and their associated membrane proteins. Transf. Med. 7, 179\u2013188 (1997).","journal-title":"Transf. Med."},{"key":"17060_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14750","volume":"8","author":"K Trakarnsanga","year":"2017","unstructured":"Trakarnsanga, K. et al. An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells. Nat. Commun. 8, 14750 (2017).","journal-title":"Nat. Commun."},{"key":"17060_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"17060_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826 (2013).","journal-title":"Science"},{"key":"17060_CR16","doi-asserted-by":"publisher","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","volume":"44","author":"FO Bagger","year":"2016","unstructured":"Bagger, F. O. et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 44, D917\u2013D924 (2016).","journal-title":"Nucleic Acids Res."},{"key":"17060_CR17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1046\/j.1537-2995.2000.40091132.x","volume":"40","author":"W Montgomery","year":"2000","unstructured":"Montgomery, W. et al. MAM: a \u201cnew\u201d high-incidence antigen found on multiple cell lines. Transfusion 40, 1132\u20131139 (2000).","journal-title":"Transfusion"},{"key":"17060_CR18","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1182\/blood-2011-09-376475","volume":"119","author":"RE Griffiths","year":"2012","unstructured":"Griffiths, R. E. et al. Maturing reticulocytes internalize plasma membrane in glycophorin A-containing vesicles that fuse with autophagosomes before exocytosis. Blood 119, 6296\u20136306 (2012).","journal-title":"Blood"},{"key":"17060_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen, C., Zhao, S., Karnad, A. & Freeman, J. W. The biology and role of CD44 in cancer progression: therapeutic implications. J. Hematol. Oncol. 11, 64 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"17060_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.5966\/sctm.2015-0048","volume":"4","author":"Y Yan","year":"2015","unstructured":"Yan, Y., Zuo, X. & Wei, D. Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Transl. Med. 4, 1033\u20131043 (2015).","journal-title":"Stem Cells Transl. Med."},{"key":"17060_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1242\/jcs.00954","volume":"117","author":"RF Thorne","year":"2004","unstructured":"Thorne, R. F., Legg, J. W. & Isacke, C. M. The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. J. Cell Sci. 117, 373\u2013378 (2004).","journal-title":"J. Cell Sci."},{"key":"17060_CR22","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.4049\/jimmunol.171.8.4062","volume":"171","author":"T Shoham","year":"2003","unstructured":"Shoham, T. et al. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment. J. Immunol. 171, 4062\u20134072 (2003).","journal-title":"J. Immunol."},{"key":"17060_CR23","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1182\/blood-2016-04-711630","volume":"128","author":"A Roy","year":"2016","unstructured":"Roy, A. et al. Activity of nonmuscle myosin II isoforms determines localization at the cleavage furrow of megakaryocytes. Blood 128, 3137\u20133145 (2016).","journal-title":"Blood"},{"key":"17060_CR24","doi-asserted-by":"publisher","first-page":"17413","DOI":"10.1073\/pnas.0909296106","volume":"106","author":"K Chen","year":"2009","unstructured":"Chen, K. et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc. Natl Acad. Sci. USA 106, 17413\u201317418 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17060_CR25","doi-asserted-by":"publisher","first-page":"14343","DOI":"10.18632\/oncotarget.11102","volume":"8","author":"F Jun","year":"2017","unstructured":"Jun, F. et al. Epithelial membrane protein 3 regulates TGF-\u03b2 signaling activation in CD44-high glioblastoma. Oncotarget 8, 14343\u201314358 (2017).","journal-title":"Oncotarget"},{"key":"17060_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/voxs.12374","volume":"13","author":"CE Severn","year":"2018","unstructured":"Severn, C. E. & Toye, A. M. The challenge of growing enough reticulocytes for transfusion. ISBT Sci. Ser. 13, 80\u201386 (2018).","journal-title":"ISBT Sci. Ser."},{"key":"17060_CR27","unstructured":"Judd, J.W., Johnson, S.T. & Storry, J. Judd\u2019s Methods in Immunohematology, 3rd ed. (AABB Press, 2008)."},{"key":"17060_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"17060_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178\u2013192 (2013).","journal-title":"Brief. Bioinform."},{"key":"17060_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/cyto.b.21488","volume":"94","author":"BK Singleton","year":"2018","unstructured":"Singleton, B. K. et al. CD44 as a potential screening marker for preliminary differentiation between congenital dyserythropoietic anemia type II and hereditary spherocytosis. Cytom. B Clin. Cytom. 94, 312\u2013326 (2018).","journal-title":"Cytom. B Clin. Cytom."},{"key":"17060_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nbt1047","volume":"23","author":"MC Giarratana","year":"2005","unstructured":"Giarratana, M. C. et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat. Biotechnol. 23, 69\u201374 (2005).","journal-title":"Nat. Biotechnol."},{"key":"17060_CR32","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1182\/blood-2010-07-295550","volume":"117","author":"J Flygare","year":"2011","unstructured":"Flygare, J., Rayon Estrada, V., Shin, C., Gupta, S. & Lodish, H. F. HIF1alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal. Blood 117, 3435\u20133444 (2011).","journal-title":"Blood"},{"key":"17060_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1423-0410.1991.tb00871.x","volume":"60","author":"FA Spring","year":"1991","unstructured":"Spring, F. A. & Reid, M. E. Evidence that the human blood group antigens Gya and Hy are carried on a novel glycosylphosphatidylinositol-linked erythrocyte membrane glycoprotein. Vox Sang. 60, 53\u201359 (1991).","journal-title":"Vox Sang."},{"key":"17060_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1126\/science.1261833","volume":"347","author":"Y Saitoh","year":"2015","unstructured":"Saitoh, Y. et al. Crystal structure of mouse claudin-19 in complex with c-terminal fragment of Claustridium perfringens enterotoxin. Science 347, 775\u2013778 (2015).","journal-title":"Science"},{"key":"17060_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1615\/CritRevOncog.v20.i5-6.140","volume":"20","author":"N Ashki","year":"2015","unstructured":"Ashki, N., Gordon, L. & Wadehrab, M. Review of the GAS3 family of proteins and their relevance to cancer. Crit. Rev. Oncog. 20, 435\u2013447 (2015).","journal-title":"Crit. Rev. Oncog."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17060-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17060-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17060-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T23:51:00Z","timestamp":1670284260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17060-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17060"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17060-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"11 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent application (PCT Application No. PCT\/GB2019\/053102) covering ex vivo erythroid cell culture proliferation enhancement due to lack of or disruption of EMP3 has been filed (N.T., C.A.G., L.T., V.K.C. and D.J.A.). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3569"}}